Non-dilutive capital and procurement
SBIR vs. STTR: Which Program, Which Agency, and How to Choose
A decision tree for founders choosing between research partnerships, customer discovery, and government-funded prototypes.
Atomic answer
SBIR and STTR are not interchangeable. SBIR is usually better for company-led commercialization. STTR is built around formal research collaboration. The right choice depends on technical maturity, university or lab dependency, agency fit, and downstream procurement path.
When Is STTR the Better Route?
STTR requires a formal research institution partner - a university, federally funded R&D center (FFRDC), or Department of Energy national lab - that performs at least 30% of the R&D work. The small business must perform at least 40%, with the remaining 30% split between either party. This is the structural difference from SBIR, where the small business must perform at least two-thirds of the work (67%) in Phase I and at least 50% in Phase II, with no mandatory institutional partner. STTR is the better route when: • You need deep research collaboration. If your technology requires ongoing access to specialized lab equipment, subject-matter expertise, or proprietary datasets housed at a university or federal lab, STTR gives you the contractual framework to formalize that relationship with funded R&D work. • You’re commercializing federally-funded university IP. When core IP originated in a university lab under federal grants, STTR allows the original researchers to continue contributing while the startup builds the commercial pathway. SBIR can also involve university subcontractors, but STTR makes the partnership a structural requirement, not an afterthought. • You lack in-house R&D facilities. Early-stage defense-tech startups rarely own wind tunnels, clean rooms, radiation testing facilities, or high-performance computing clusters. STTR allows you to contract that capacity from a partner institution without building it yourself. SBIR is better when: • Company-led commercialization. SBIR keeps the IP, the work plan, and the decision-making authority inside the company. Founders who want full control over the technical roadmap and IP strategy prefer SBIR. • Internal R&D capability. If your founding team has the bench strength - PhD engineers, in-house lab space, prototype fabrication - SBIR rewards that depth. The Phase I-to-II transition rates are higher when the company executes the work internally (DoD SBIR Phase II transition rate: ~45% for companies with prior DoD contracting experience, per the DoD SBIR/STTR Annual Report FY2023). • Product-focused development. SBIR is built for companies that intend to sell a product. STTR’s research-collaboration structure can slow down product iteration if the institutional partner’s incentives are misaligned with commercial timelines. Comparison Table: SBIR vs. STTR at a Glance Dimension | SBIR | STTR Research partner required | No | Yes (university, FFRDC, or national lab) Work share (Phase I) | 67% small business minimum | 40% small business / 30% partner minimum Work share (Phase II) | 50% small business minimum | 40% small business / 30% partner minimum PI employment | Must be primarily employed by the small business at time of award | May be employed by the partner institution IP ownership | Small business owns IP | Small business owns IP (negotiate partner terms separately) Phase I award ceiling | Up to ~$150K (varies by agency) | Up to ~$150K (varies by agency) Best for | Product commercialization, internal R&D, founder-led IP | Deep research collaboration, university spinouts, lab-dependent technology Source: SBA SBIR/STTR Policy Directive (May 2019, amended 2023). Phase I award ceilings updated per agency-specific solicitations.What Makes an Agency Fit Real?
The eleven federal agencies that participate in SBIR/STTR are not interchangeable funders. Each runs its own solicitation cycle, has its own evaluation criteria, and - most critically - has its own downstream procurement culture that determines whether a Phase II prototype becomes a Phase III contract. Department of Defense (DoD): The most heavily funded SBIR/STTR program at over $1.8 billion annually (DoD SBIR/STTR FY2023 Annual Report). DoD SBIR is structured around specific topics - “component science and technology areas” - each tied to a program office that can become a customer. The DoD cares about dual-use applicability and transition. If your technology solves a military problem and has commercial potential, DoD SBIR is the most heavily resourced path. The Air Force (AFWERX), Navy (NavalX), Army, and DARPA each run their own topics with distinct cultural flavors: AFWERX moves fast with pitch-day formats, DARPA prizes breakthrough science, Army tends toward systems integration. National Science Foundation (NSF): NSF SBIR/STTR invests in deep technology with commercial potential. NSF cares about intellectual merit and broader impacts - the science must be novel, and the commercialization plan must be credible. NSF runs a cohort-based Phase I program with a fixed application window (typically two cycles per year). Phase I awards up to $305,000 (including supplemental programs). The NSF I-Corps program is frequently bundled with Phase I, forcing customer discovery early. Department of Energy (DOE): DOE SBIR/STTR maps to specific technology offices - Advanced Research Projects Agency-Energy (ARPA-E), Office of Science, Fossil Energy, Nuclear Energy, etc. DOE cares about energy technology milestones more than near-term procurement. If your company builds for grid infrastructure, fusion, advanced materials, or carbon management, DOE SBIR is the primary agency. Timelines skew longer than DoD. NASA: NASA SBIR/STTR funds technologies that align with mission directorates - space operations, aeronautics, exploration systems, science. NASA cares about infusion: will this technology fly or support a mission? NASA Phase I is approximately $150,000, and many Phase II awards convert into sole-source follow-on contracts under the NASA Technology Transfer program. Health and Human Services (HHS/NIH): NIH SBIR/STTR dominates the life sciences SBIR landscape with over $1.2 billion annually. For med-tech, diagnostics, digital health, and biotech startups, NIH is the primary pathway. NIH cares about public health impact and clinical validation, not defense transition. Which Agency Fits Which Defense-Tech Startup Type? Startup profile | Best-fit agency | Why Autonomous systems, drones, C2 software | DoD (AFWERX, Army) | Direct pathway to program offices; transition contracts available AI/ML for national security | DoD (DARPA, DIU) or NSF | DARPA for breakthrough AI; NSF for civilian dual-use Space tech, launch, satellite | NASA or DoD (Space Force via AFWERX) | Mission-infusion mandate Quantum, advanced materials | DOE or DARPA | DOE lab infrastructure; DARPA for high-risk physics Energy storage, grid resilience | DOE | Energy-focused procurement pipeline Biotech, med devices for military | HHS/NIH or DoD (CDMRP) | NIH for clinical; DoD for operational medicine Real Timelines (Solicitation Close to Award Notification): DoD SBIR Phase I: 6–12 months; Phase II: 24 months NSF SBIR Phase I: 6–12 months (cohort-dependent); Phase II: 24 months DOE SBIR Phase I: 5–8 months; Phase II: 24 months NASA SBIR Phase I: 3–6 months; Phase II: 24 months NIH SBIR Phase I: 8–10 months; Phase II: 24 months Sources: DoD SBIR/STTR FY2023 Annual Report; NSF SBIR/STTR Program Portfolio; GAO Report GAO-23-106728, “SBIR/STTR: Additional Actions Needed to Improve Data and Timeliness.”How Should a Founder Write for Transition Rather Than Award Capture?
Most SBIR/STTR proposals are written to win. The winning proposals are written to transition. The difference is whether the narrative answers the reviewer’s checklist or the program office’s procurement question: “Will this technology become something I can buy?” The Phase III Opportunity That Most Founders Miss SBIR Phase III is not a grant round. It is a non-competitive, sole-source contract vehicle that allows the government to purchase your technology without running a full procurement competition. You do not apply for Phase III. You earn it by demonstrating that your Phase I/II results solve a validated problem for a specific office that has budget authority. The DoD obligated over $5.8 billion in SBIR/STTR Phase III contracts in FY2023 alone (DoD SBIR/STTR Annual Report). That capital bypasses the traditional defense acquisition timeline entirely. Writing Phase I/II with Phase III as the True Destination Every section of your proposal should reinforce one argument: “This technology transitions, and here is who buys it.” Technical objectives: Frame milestones around the minimum viable transition - not just the minimum viable product. What does the technology need to demonstrate for a program office to write a justification and approval (J&A) for sole-source procurement? Commercialization plan: Name the specific government end-user, not “the government” broadly. Identify the program office, the acquisition contact, and the funding line. The strongest proposals include a letter of support from a potential transition partner before Phase I ends. Work plan: Include a “transition risk” column alongside technical risk. If the technical milestone succeeds but the acquisition partner changes or loses funding, what is the alternative transition path? The Transition Plan Section (That Most Founders Skip) A transition plan is not a commercialization appendix. It is a specific, time-bound roadmap that answers: 1. Who is the government customer (name, office, role)? 2. What acquisition mechanism will they use (Phase III sole-source, OT, SBIR Sequential Phase II, or BA)? 3. What is their procurement window (when does funding arrive, when must the deliverable be ready)? 4. What is the technical gate between Phase II and Phase III (TRL 6 demo? operational test? safety certification?)? 5. Which private-sector customer validates dual-use demand? Founders who answer these five questions in their Phase I proposal are building a business case, not a grant application. Reviewers at DoD components and DIU recognize the difference immediately. How DIU and AFWERX Shortcut the Timeline DIU (Defense Innovation Unit) and AFWERX have compressed the traditional SBIR timeline significantly: AFWERX STTR Open Topic: Uses a rolling solicitation (not annual), accepts 15-page white papers, and can move from submission to award in under 90 days. Phase I award: $75,000 for 3 months. Phase II: up to $1.25 million over the award period. The Phase II is structured as a “Strategic Fund Increase” (STRATFI) partnership where AFWERX matches private investment 1:1 (up to $15 million for Phase III transition). DIU Commercial Solutions Opening (CSO): DIU uses Other Transaction Authority (OTA) to bypass FAR entirely. Solicitation-to-award in 60–90 days. Awards are prototype agreements with a clear path to follow-on production contracts. DIU explicitly screens for commercial viability first and government utility second - the opposite of traditional SBIR. Combining pathways: A common defense-tech playbook is: NSF Phase I for customer discovery and TRL advancement → DoD Phase II with a transition partner identified → AFWERX STRATFI for matched scaling capital → DIU production OT for procurement. According to the GAO, companies that engage transition partners during Phase I are approximately 3× more likely to receive Phase III contracts than those that wait until Phase II (GAO-24-107234, “DOD Small Business Innovation Research: Actions Needed to Improve Data and Enhance Transition Support,” 2024). FAQ Schema Include the following JSON-LD structured data on the page: { “@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [ { “@type”: “Question”, “name”: “What is the main difference between SBIR and STTR?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “SBIR does not require a research institution partner and the small business performs the majority of the R&D work (67% Phase I, 50% Phase II). STTR mandates a formal partnership with a university, FFRDC, or national lab, with work split at minimum 40% small business / 30% partner. SBIR is designed for company-led commercialization; STTR is built for deep research collaboration.” } }, { “@type”: “Question”, “name”: “Which agency has the largest SBIR/STTR budget for defense tech startups?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “The Department of Defense (DoD) has the largest SBIR/STTR budget at over $1.8 billion annually. Within DoD, components like AFWERX, DARPA, the Army, and the Navy each run their own topic areas with distinct timelines and transition cultures. NSF ($250M+), DOE, and HHS/NIH (over $1.2B) are the other major SBIR agencies.” } }, { “@type”: “Question”, “name”: “How long does it take to go from SBIR Phase I application to Phase III contract?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “A typical SBIR timeline: Phase I is 6–12 months (solicitation to award), Phase I execution is 6–12 months, Phase II proposal and award is 6–12 months, Phase II execution is up to 24 months. Transition to Phase III can begin during Phase II if a government customer is engaged early. Accelerated pathways like AFWERX Open Topic and DIU CSO can compress Phase I solicitation-to-award to under 90 days.” } } ] }Stack & State is an editorial and ecosystem-intelligence publication. Nothing here is legal, investment, procurement, or compliance advice. Program details change; verify requirements with primary sources and qualified advisors.